Choice A rationale An ultrasound for structural anomalies is primarily utilized earlier in pregnancy, often around 18-20 weeks, to identify gross physical defects. While it can confirm fetal position and fluid volume, it does not provide a comprehensive, real-time physiological assessment of fetal well-being and oxygenation status, which is the immediate concern following a concerning nonstress test near term. Choice B rationale Maternal serum alpha-fetoprotein (MSAFP) screening is performed much earlier, typically between 15 and 20 weeks of gestation, to screen for neural tube defects and chromosomal abnormalities like Down syndrome. This biochemical test is entirely unrelated to the immediate assessment of fetal oxygenation and well-being in a 41-week pregnancy with a non-reassuring nonstress test result. Choice C rationale Percutaneous umbilical blood sampling (PUBS) is a highly invasive procedure involving needle insertion into the umbilical cord vessel to obtain a fetal blood sample. It is reserved for specific, high-risk diagnostic needs, such as confirming severe anemia or infection, and is not a routine non-invasive tool for initial, detailed, real-time assessment of fetal well-being after a nonstress test. Choice D rationale The Biophysical Profile (BPP) is the non-invasive diagnostic tool that combines a nonstress test with an ultrasound assessment of four key fetal physiological parameters: fetal breathing movements, gross body movements, fetal tone, and amniotic fluid volume. This comprehensive scoring system directly and immediately reflects fetal oxygenation status and current well-being, making it the most appropriate follow-up.